TWST
Twist Bioscience Corp
158.50$
-3.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.6% | 53.3% | 52.9% | 56.7% | 56.4% | 56.7% | 56.8% | 52.8% | 51.9% | 47.6% | 47.8% | 47.8% | |
| 36.9% | 36.3% | 34.6% | 37.5% | 36.8% | 36.4% | 35.3% | 31.3% | 28.5% | 23.3% | 18.1% | 17.5% | |
| 43.3% | 42.5% | 41.7% | 45.4% | 45.0% | 44.5% | 43.2% | 39.0% | 36.2% | 31.0% | 25.4% | 24.8% | |
| 5.7% | 5.0% | 5.3% | 5.0% | 5.7% | 6.5% | 8.4% | 7.7% | 8.9% | 7.8% | 9.5% | 9.8% | |
| 4.1% | 4.2% | 4.3% | 4.5% | 3.9% | 3.9% | 3.5% | 4.0% | 4.4% | 5.2% | 5.0% | 5.2% | |
| 11.1% | 11.7% | 12.2% | 13.4% | 14.0% | 14.1% | 14.4% | 12.8% | 12.8% | 12.9% | 12.2% | 12.2% | |
| 7.0% | 7.3% | 7.4% | 2.3% | 2.4% | 2.3% | 2.3% | 2.1% | 2.1% | 2.1% | 1.9% | 1.9% | |
| 19.7% | 19.5% | 20.3% | 23.0% | 23.1% | 25.1% | 26.1% | 25.7% | 26.3% | 28.5% | 32.7% | 33.7% | |
| 9.4% | 8.9% | 9.6% | 11.6% | 11.6% | 11.4% | 12.6% | 13.5% | 14.2% | 12.6% | 17.7% | 17.9% | |
| 1.9% | 2.0% | 2.1% | 2.3% | 2.4% | 2.5% | 2.6% | 2.4% | 2.2% | 1.9% | 1.5% | 1.3% | |
| 1.8% | 1.3% | 1.1% | 1.0% | 0.3% | 1.2% | 1.4% | 1.9% | 1.7% | 2.0% | 2.2% | 2.5% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | |
| 80.3% | 80.5% | 79.7% | 77.0% | 76.9% | 74.9% | 73.9% | 74.3% | 73.7% | 71.5% | 67.3% | 66.3% | |
| -133.1% | -146.9% | -159.6% | -189.2% | -202.2% | -209.3% | -220.4% | -200.8% | -205.6% | -211.6% | -206.2% | -212.5% | |
| 7.4% | 7.8% | 8.2% | 9.1% | 9.4% | 9.7% | 10.0% | 9.5% | 9.4% | 9.6% | 9.1% | 9.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.